Tern portfolio company Device Authority wins Microsoft award

TERN

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, has noted that Device Authority Limited, a company in which Tern currently holds 53.8% of the equity, has announced that it has won the Rising Azure Technology 2023 Microsoft Partner of the Year Award. Device Authority was honored among a global field of Microsoft partners for demonstrating excellence in innovation and implementation of customer solutions based on Microsoft technology.

Device Authority CEO, Darron Antill commented“We are delighted that Keyscaler-as-a-service (KsaaS), our cloud-first approach to automated end-to-end device security has been recognized with this award. With today’s global supply chains increasingly relying on interconnected devices and the relaying of timely data to artificial intelligence systems, trust in devices has never been more important. Because these devices are often located outside of the secured network environment, they’ve become a target for bad actors, and a single disruption to a production line can cost an organization up to 5% of its annual profits.

“Leveraging Azure’s capabilities, KSaaS provides an automated and scalable solution to our customers’ device security problems, accelerating their digital transformation and providing resilience throughout their connected infrastructure.”

The Microsoft Partner of the Year Awards recognise Microsoft partners that have developed and delivered outstanding Microsoft-based applications, services and devices during the past year. Awards were classified in various categories, with honorees chosen from a set of more than 4,200 submitted nominations from more than 100 countries worldwide. Device Authority was recognised for providing outstanding solutions and services in Global Rising Azure Technology.

The award recognises a technology partner that has demonstrated strong customer focus and impact by building on Microsoft Azure as their primary cloud platform and scaling their solution by selling with Microsoft. The winning partner solution clearly demonstrates the value of repeatable IP and showcases how technology can solve differentiated value, addresses a unique market need, and improves the customer experience.

The Microsoft Partner of the Year Awards are announced annually prior to the company’s global partner conference, Microsoft Inspire, which will take place on July 18-19 this year. Additional details on the 2023 awards are available on the Microsoft Partner blog: https://aka.ms/POTYA2023_announcement. The complete list of categories, winners and finalists can be found at https://partner.microsoft.com/en-US/inspire/awards/winners.

Tern plc is using its experience in pioneering leading-edge tech combined with a deep reach into expanding world markets to unlock the potential of UK companies who may be starting local, but are dreaming global.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Search